Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Apr;114(7):1351–1358. doi: 10.1111/j.1476-5381.1995.tb13355.x

Selective modification of rat hepatic microsomal fatty acid chain elongation and desaturation by fibrates: relationship with peroxisome proliferation.

M Alegret 1, E Cerqueda 1, R Ferrando 1, M Vázquez 1, R M Sánchez 1, T Adzet 1, M Merlos 1, J C Laguna 1
PMCID: PMC1510293  PMID: 7606338

Abstract

1. The time-course of the effect of clofibrate (CFB), bezafibrate (BFB) and gemfibrozil (GFB) on lipid plasma levels and palmitoyl-, palmitoleoyl- and gamma-linolenoyl-CoA elongase, delta-9, delta-6 and delta-5 desaturase activities, and microsomal electron transport chains, as well as the correlation with the peroxisomal proliferation phenomenon have been studied in male Sprague-Dawley rats. 2. As reported in our previous work, the three drugs behave as peroxisomal proliferators (the order of potency was BFB > CFB > or = GFB) and induced a clear reduction in both plasma cholesterol and triglyceride levels. 3. Palmitoyl-CoA elongation activity was increased by the three drugs (BFB = GFB > CFB), whereas palmitoleoyl-CoA elongation activity was only enhanced by GFB. Elongation activity was not modified by fibrates when gamma-linolenoyl-CoA was used as substrate. These results are in accordance with the existence of three different elongation systems for saturated, mono- and polyunsaturated fatty acids. 4. delta-9, delta-6 and delta-5 desaturase activities were increased by the three fibrates, with an order of potency BFB > CFB = GFB for delta-9 and delta-5, and GFB > BFB = CFB for delta-6. 5. Of the enzyme activities integrated in the microsomal electron transport chains, NADH cytochrome b5 reductase was not affected by fibrate treatment, NADPH cytochrome c reductase activity was enhanced (BFB = GFB > CFB), whereas NADH cytochrome c reductase activity was reduced by CFB and BFB.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Actis Dato S. M., Catala A., Brenner R. R. Circadian rhythm of fatty acid desaturation in mouse liver. Lipids. 1973 Jan;8(1):1–6. doi: 10.1007/BF02533231. [DOI] [PubMed] [Google Scholar]
  2. Agheli N., Jacotot B. Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients. Br J Clin Pharmacol. 1991 Oct;32(4):423–428. doi: 10.1111/j.1365-2125.1991.tb03925.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alegret M., Ferrando R., Vázquez M., Adzet T., Merlos M., Laguna J. C. Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates. Br J Pharmacol. 1994 Jun;112(2):551–556. doi: 10.1111/j.1476-5381.1994.tb13109.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Alegret M., Sánchez R., Adzet T., Merlos M., Laguna J. C. In vitro effect of clofibric acid derivatives on rat hepatic microsomal electron transport chains. Biochem Pharmacol. 1991 Oct 24;42(10):2057–2060. doi: 10.1016/0006-2952(91)90610-h. [DOI] [PubMed] [Google Scholar]
  5. Bernert J. T., Jr, Sprecher H. An analysis of partial reactions in the overall chain elongation of saturated and unsaturated fatty acids by rat liver microsomes. J Biol Chem. 1977 Oct 10;252(19):6736–6744. [PubMed] [Google Scholar]
  6. Bernert J. T., Jr, Sprecher H. Factors regulating the elongation of palmitic and stearic acid by rat liver microsomes. Biochim Biophys Acta. 1979 Jul 27;574(1):18–24. doi: 10.1016/0005-2760(79)90079-1. [DOI] [PubMed] [Google Scholar]
  7. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  8. Catapano A. L. Mode of action of fibrates. Pharmacol Res. 1992 Dec;26(4):331–340. doi: 10.1016/1043-6618(92)90232-z. [DOI] [PubMed] [Google Scholar]
  9. Cinti D. L., Cook L., Nagi M. N., Suneja S. K. The fatty acid chain elongation system of mammalian endoplasmic reticulum. Prog Lipid Res. 1992;31(1):1–51. doi: 10.1016/0163-7827(92)90014-a. [DOI] [PubMed] [Google Scholar]
  10. ELLMAN G. L. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959 May;82(1):70–77. doi: 10.1016/0003-9861(59)90090-6. [DOI] [PubMed] [Google Scholar]
  11. Endo A. Chemistry, biochemistry, and pharmacology of HMG-CoA reductase inhibitors. Klin Wochenschr. 1988 May 16;66(10):421–427. doi: 10.1007/BF01745510. [DOI] [PubMed] [Google Scholar]
  12. Hanefeld M., Kemmer C., Kadner E. Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis. 1983 Feb;46(2):239–246. doi: 10.1016/0021-9150(83)90115-6. [DOI] [PubMed] [Google Scholar]
  13. Hawkins J. M., Jones W. E., Bonner F. W., Gibson G. G. The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab Rev. 1987;18(4):441–515. doi: 10.3109/03602538708994130. [DOI] [PubMed] [Google Scholar]
  14. Kawashima Y., Hanioka N., Matsumura M., Kozuka H. Induction of microsomal stearoyl-CoA desaturation by the administration of various peroxisome proliferators. Biochim Biophys Acta. 1983 Jul 12;752(2):259–264. [PubMed] [Google Scholar]
  15. Kawashima Y., Hirose A., Kozuka H. Alterations by peroxisome proliferators of acyl composition of hepatic phosphatidylcholine in rats, mice and guinea-pigs. Role of stearoyl-CoA desaturase. Biochem J. 1986 Apr 1;235(1):251–255. doi: 10.1042/bj2350251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kawashima Y., Hirose A., Kozuka H. Modification by clofibric acid of acyl composition of glycerolipids in rat liver. Possible involvement of fatty acid chain elongation and desaturation. Biochim Biophys Acta. 1984 Oct 4;795(3):543–551. doi: 10.1016/0005-2760(84)90184-x. [DOI] [PubMed] [Google Scholar]
  17. Kawashima Y., Musoh K., Kozuka H. Peroxisome proliferators enhance linoleic acid metabolism in rat liver. Increased biosynthesis of omega 6 polyunsaturated fatty acids. J Biol Chem. 1990 Jun 5;265(16):9170–9175. [PubMed] [Google Scholar]
  18. Kawashima Y., Uy-Yu N., Kozuka H. Sex-related differences in the enhancing effects of perfluoro-octanoic acid on stearoyl-CoA desaturase and its influence on the acyl composition of phospholipid in rat liver. Comparison with clofibric acid and tiadenol. Biochem J. 1989 Nov 1;263(3):897–904. doi: 10.1042/bj2630897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Keyes S. R., Cinti D. L. Biochemical properties of cytochrome b5-dependent microsomal fatty acid elongation and identification of products. J Biol Chem. 1980 Dec 10;255(23):11357–11364. [PubMed] [Google Scholar]
  20. Laguna J. C., Nagi M. N., Cook L., Cinti D. L. Action of Ebselen on rat hepatic microsomal enzyme-catalyzed fatty acid chain elongation, desaturation, and drug biotransformation. Arch Biochem Biophys. 1989 Feb 15;269(1):272–283. doi: 10.1016/0003-9861(89)90109-4. [DOI] [PubMed] [Google Scholar]
  21. Lake B. G., Gray T. J. Species differences in hepatic peroxisome proliferation. Biochem Soc Trans. 1985 Oct;13(5):859–861. doi: 10.1042/bst0130859. [DOI] [PubMed] [Google Scholar]
  22. Landriscina C., Ruggiero F. M., Gnoni G. V., Quagliariello E. Reduced activity of hepatic microsomal fatty acid chain elongation synthesis in clofibrate-fed rats. Biochem Pharmacol. 1977 Aug 1;26(15):1401–1404. doi: 10.1016/0006-2952(77)90364-1. [DOI] [PubMed] [Google Scholar]
  23. McGuire E. J., Lucas J. A., Gray R. H., de la Iglesia F. A. Peroxisome induction potential and lipid-regulating activity in rats. Quantitative microscopy and chemical structure-activity relationships. Am J Pathol. 1991 Jul;139(1):217–229. [PMC free article] [PubMed] [Google Scholar]
  24. Milton M. N., Elcombe C. R., Gibson G. G. On the mechanism of induction of microsomal cytochrome P450IVA1 and peroxisome proliferation in rat liver by clofibrate. Biochem Pharmacol. 1990 Dec 15;40(12):2727–2732. doi: 10.1016/0006-2952(90)90594-b. [DOI] [PubMed] [Google Scholar]
  25. Nagi M. N., Laguna J. C., Cook L., Cinti D. L. Disruption of rat hepatic microsomal electron transport chains by the selenium-containing anti-inflammatory agent Ebselen. Arch Biochem Biophys. 1989 Feb 15;269(1):264–271. doi: 10.1016/0003-9861(89)90108-2. [DOI] [PubMed] [Google Scholar]
  26. Prasad M. R., Nagi M. N., Ghesquier D., Cook L., Cinti D. L. Evidence for multiple condensing enzymes in rat hepatic microsomes catalyzing the condensation of saturated, monounsaturated, and polyunsaturated acyl coenzyme A. J Biol Chem. 1986 Jun 25;261(18):8213–8217. [PubMed] [Google Scholar]
  27. Reddy J. K., Lalwani N. D., Qureshi S. A., Reddy M. K., Moehle C. M. Induction of hepatic peroxisome proliferation in nonrodent species, including primates. Am J Pathol. 1984 Jan;114(1):171–183. [PMC free article] [PubMed] [Google Scholar]
  28. Sirtori C. R., Calabresi L., Werba J. P., Franceschini G. Tolerability of fibric acids. Comparative data and biochemical bases. Pharmacol Res. 1992 Oct-Nov;26(3):243–260. doi: 10.1016/1043-6618(92)90212-t. [DOI] [PubMed] [Google Scholar]
  29. Sánchez R. M., Alegret M., Adzet T., Merlos M., Laguna J. C. Differential inhibition of long-chain acyl-CoA hydrolases by hypolipidemic drugs in vitro. Biochem Pharmacol. 1992 Feb 4;43(3):639–644. doi: 10.1016/0006-2952(92)90589-b. [DOI] [PubMed] [Google Scholar]
  30. Sánchez R. M., Viñals M., Alegret M., Vázquez M., Adzet T., Merlos M., Laguna J. C. Fibrates modify rat hepatic fatty acid chain elongation and desaturation in vitro. Biochem Pharmacol. 1993 Nov 17;46(10):1791–1796. doi: 10.1016/0006-2952(93)90584-j. [DOI] [PubMed] [Google Scholar]
  31. Sánchez R. M., Viñals M., Alegret M., Vázquez M., Adzet T., Merlos M., Laguna J. C. Inhibition of rat liver microsomal fatty acid chain elongation by gemfibrozil in vitro. FEBS Lett. 1992 Mar 23;300(1):89–92. doi: 10.1016/0014-5793(92)80170-l. [DOI] [PubMed] [Google Scholar]
  32. Sánchez R. M., Vázquez M., Alegret M., Viñals M., Adzet T., Merlos M., Laguna J. C. Cytosolic lipogenic enzymes: effect of fibric acid derivatives in vitro. Life Sci. 1993;52(2):213–222. doi: 10.1016/0024-3205(93)90142-p. [DOI] [PubMed] [Google Scholar]
  33. Tavella M., Corder C. N., McConathy W. Effect of gemfibrozil on fatty acids in lipid fractions of plasma from patients with hypertriglyceridemia. J Clin Pharmacol. 1993 Jan;33(1):35–39. doi: 10.1002/j.1552-4604.1993.tb03900.x. [DOI] [PubMed] [Google Scholar]
  34. Vessby B., Lithell H. Interruption of long-term lipid-lowering treatment with bezafibrate in hypertriglyceridaemic patients. Effects on lipoprotein composition, lipase activities and the plasma lipid fatty acid spectrum. Atherosclerosis. 1990 May;82(1-2):137–143. doi: 10.1016/0021-9150(90)90152-9. [DOI] [PubMed] [Google Scholar]
  35. Vázquez M., Alegret M., Adzet T., Merlos M., Laguna J. C. Gemfibrozil modifies acyl composition of liver microsomal phospholipids from guinea-pigs without promoting peroxisomal proliferation. Biochem Pharmacol. 1993 Oct 19;46(8):1515–1518. doi: 10.1016/0006-2952(93)90121-c. [DOI] [PubMed] [Google Scholar]
  36. Wang C. S., Hartsuck J., McConathy W. J. Structure and functional properties of lipoprotein lipase. Biochim Biophys Acta. 1992 Jan 3;1123(1):1–17. doi: 10.1016/0005-2760(92)90165-r. [DOI] [PubMed] [Google Scholar]
  37. Waxman D. J., Azaroff L. Phenobarbital induction of cytochrome P-450 gene expression. Biochem J. 1992 Feb 1;281(Pt 3):577–592. doi: 10.1042/bj2810577. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES